Georgetown-Lombardi Cancer Center — Washington D.C., District of Columbia

Georgetown-Lombardi Cancer Center is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Georgetown-Lombardi Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Advanced Hepatocellular Carcinoma, Liver Cancer, Hepatic Cancer.

Sponsors: Daiichi Sankyo.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgetown-Lombardi Cancer Center?

Georgetown-Lombardi Cancer Center has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgetown-Lombardi Cancer Center conducted?

Georgetown-Lombardi Cancer Center has 1 clinical trials on record. Their work covers Advanced Hepatocellular Carcinoma, Liver Cancer, Hepatic Cancer.

Is Georgetown-Lombardi Cancer Center accredited by Crixeo Health?

Georgetown-Lombardi Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgetown-Lombardi Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.